Study of subclinical hypothyroidism in elderly and its correlation with lipid profile

Authors

  • Namita Mohanty Department of General Medicine, Maharaja Krishna Chandra Gajapati Medical College, Berhampur, Odisha, India
  • Satyajit Parhi Department of General Medicine, Maharaja Krishna Chandra Gajapati Medical College, Berhampur, Odisha, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20196077

Keywords:

Correlation, Dyslipidemia, Elderly, Subclinical hypothyroidism

Abstract

Background: Although hypothyroidism accompanying dyslipidemia previously recognized as important risk factor for cardiovascular disease, but now subclinical hypothyroidism emerged as important risk factor for atherosclerosis and myocardial infarction especially in elderly people. Subclinical Hypothyroidism (SCH) is a state characterized by normal serum T3 and T4 level with elevated TSH level having minimal signs and symptoms. There are limited studies on SCH and dyslipidemia in elderly people in India, so this study was undertaken to correlate thyroid function abnormality with lipid profile in elderly population. 

Methods: This observational study was conducted in 74 elderly people more than 60 years age group having symptoms of SCH i.e. fatigue, weakness mild thyroid swelling, weight gain etc. who did not previously have a diagnosis of hypothyroidism, diabetes mellitus, previous thyroidectomy, renal failure, hepatic failure, systemic hypertension etc. They had normal T3, T4 level and raised TSH value. Cases with TSH value >5 mIU/L but normal T3, T4 level were evaluated further for lipid profile. 

Results: Elderly females suffered more from SCH in the age group of 60-70 years. Participants with SCH had significantly higher cholesterol (p value=0.0216), higher LDL (p value=0.0241) and higher triglyceride (p value =0.0004) with increasing TSH showing positive correlation. There is no significant correlation between decreasing HDL and TSH value.

Conclusions: All elderly people should be routinely screened for thyroid function abnormality. Those have SCH should also be evaluated for dyslipidemia so that they can be treated with lipid lowering drugs and low dose thyroxine judiciously to prevent atherosclerosis.

References

Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Annal Family Med. 2004;2(4):351-5.

Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Europ J Endocrinol. 2011;164(3):317-23.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archiv Inter Med. 2000;160(4):526-34.

Hak L, Pols H, Visser T, Drexhage H, Witteman J, Hofman A. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annal Inter Med. 2000;1.

Bandyopadhyay SK, Basu AK, Pal SK, Roy P, Chakrabarti S, Pathak HS, et al. A study on dyslipidaemia in subclinical hypothyroidism. J Ind Med Associat. 2006;104(11):622-4.

Lee J, Chung WY. Subclinical Hypothyroidism; Natural History, Long-Term Clinical Effects and Treatment. In Curr Topics Hypothyroid Focus Development 2013;13.

Franklyn JA. The thyroid-too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol. 2013;78(1):1-8.

Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7(6):481-93.

Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metabol. 2002;87(2):489-99.

Kong WM, Sheikh M, Lumb P, Naoumova RP, Freedman DB, Finer N. A randomized controlled trial of thyroxine treatment in mild subclinical hypothyroidism. In Program and abstracts: the Endocrine Society’s 82nd annual meeting, Toronto 2000. Am J Med. 2002;112(5):348-54.

Pipliwal PS, Mathur R, Mathur A, Kumar A. A study to compare the clinical profile and Labortary Abnormalities in the subclinical hypothyroidism with healthy control. IOSR J. 2017;16(1):97-100.

Hennessey JV, Espaillat R. Diagnosis and management of subclinical hypothyroidism in elderly adults: A review of the literatures. J Am Geriatric Soci. 2015; 63(8):1663-73.

Waring AC, Arnold AM, Newman AB, Bùžková P, Hirsch C, Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metabol. 2012;97(11):3944-50.

Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: The Health, Ageing and Body Composition Study. Clin Endocrinol. 2012;76(6):911-8.

Dubey T, Upadhyay V, Deopujari K. Correlation of Subclinical Hypothyroidism with Dyslipidemia in Perimenopausal Women. IJCMR. 2016;3(7):1928-31.

Al Sayed A, Al Ali N, Bo Abbas Y, Alfadhli E. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocr J. 2006;53(5):653-7.

Jayasingh IA, Puthuran P. Subclinical hypothyroidism and the risk of hypercholesterolemia. J Family Med Primary Care. 2016;5(4):809.

Guntaka M, Hanmayyagari B, Rosaline M, Nagesh V. Lipid profile in subclinical hypothyroidism: A biochemical study from tertiary care hospital. Chrismed J Health Res. 2014;1(4):266.

Downloads

Published

2020-01-27

How to Cite

Mohanty, N., & Parhi, S. (2020). Study of subclinical hypothyroidism in elderly and its correlation with lipid profile. International Journal of Research in Medical Sciences, 8(2), 444–449. https://doi.org/10.18203/2320-6012.ijrms20196077

Issue

Section

Original Research Articles